N/A
N=6
Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness
Respiratory Disease · Asthma in Children · Pneumonia in Children · Bronchiolitis Acute
Bottom Line
View on ClinicalTrials.gov: NCT04407806 ↗Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Length of Stay, Measured in Days — 1.15; 1.04 days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Continous Pulse oximeter (Device); Intermittent Pulse oximeter (Device)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- Corewell Health East
- Primary completion
- May 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Length of Stay, Measured in Days |
1.15; 1.04 | — |
| SECONDARY Comfort of Parents: Level of Care Their Child Received in Hospital |
5; 5 | — |
| SECONDARY Comfort of Parents: Continuing to Care for Their Child at Home |
5; 3 | — |
| SECONDARY Frequency of Nurse Responses to Pulse Oximetry Alarms |
— | — |
| SECONDARY Frequency of Pulse Oximetry Alarms Require Medical Intervention |
— | — |
Summary
This is a randomized, prospective study to determine if there is a difference in hospital length of stay between patients receiving continuous hardwire cardiorespiratory monitoring and those receiving intermittent vital signs measurements among pediatric patients admitted for uncomplicated respiratory illness.
Eligibility Criteria
Inclusion Criteria
- Admission for respiratory illness
- Corrected gestational age greater than 3 months
- Age less than or equal to 14 years old
- Admission to Beaumont children's Hospital Pediatric unit, or transfer to pediatric unit from the Beaumont Children's hospital
Exclusion Criteria
- Primary admission from non-respiratory illness
- Corrected gestational age less than 3 months
- Age greater thn 14 years ld
- History of chronic lung disease and age less than 1 year
- Home oxygen use
- Tracheostomy dependent
- Neuro-muscular disease of hypotonia secondary to chronic/congenital disease
- Cardiac malformation treated with medicatio
Data sourced from ClinicalTrials.gov (NCT04407806). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.